Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 100,000 shares at $7.04 ($704K) on 2021-06-16, disclosed to the SEC on 2021-06-21.
Seasonal sale ($704k) by President and CEO — this insider has traded CTMX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |